Bring online safety mentions into an organised review process.
Support pharmacovigilance teams with product-specific monitoring, AI-assisted screening and defined review workflows across agreed online sources.
- Agree
- Define
- Test
- Monitor
What is ADR Social Listening?.
Definition
ADR Social Listening is a digital monitoring solution that helps identify potential adverse event mentions in accessible online content. It organises relevant information for assessment and handover by authorised pharmacovigilance teams.
The challenge it addresses
Patients and caregivers may describe medicine-related experiences on social platforms, review sites and forums. Relevant mentions can be difficult to locate and organise within the monitoring scope agreed by a company and its safety team.
What the solution does.
Monitor agreed sources
Track selected product names, brand terms and related keywords where source access permits.
Screen potential mentions
Use AI-assisted screening to organise content that may warrant safety-team assessment.
Route information for review
Use agreed alerts, reviewer assignments and escalation workflows.
Maintain review traceability
Track source references, review status and handover records, with reporting on monitoring activity.
From scoping to rollout.
- Agree
Agree on the products, sources, access conditions and review responsibilities. - Define
Define screening and escalation criteria. - Test
Test the workflow with the safety team. - Monitor
Monitor screening performance during operation.
Who it is for
Pharmaceutical companies, marketing authorisation holders and pharmacovigilance service providers seeking a structured review process for online medicine-related discussions.
Where it can help
Selected-brand monitoring, potential safety-mention screening, reviewer coordination and documentation of monitoring activity.
The value for your safety team
Relevant online content moves through a defined review process, with clearer ownership and traceability from source to handover.
Questions teams ask us.
Does an online mention confirm an adverse drug reaction?
No. An online mention is information for assessment. Qualified reviewers determine case validity, whether further information is needed and what action to take under established pharmacovigilance procedures.
Does this replace a safety database?
The solution supports monitoring, screening and review handover. Case processing, assessment and regulatory submission remain within the organisation’s established safety operating model.
Define the monitoring scope your team needs.
Discuss your products, sources and review requirements with us.